Olema Pharmaceuticals, Inc.
OLMA
$5.59
-$0.17-2.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.08% | 9.47% | 2.86% | -13.74% | 1.90% |
| Total Depreciation and Amortization | 3.13% | 10.34% | 22.11% | 1.06% | 6.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.42% | -48.63% | 27.55% | 2.43% | 34.41% |
| Change in Net Operating Assets | 164.50% | -848.25% | -38.37% | 424.84% | -123.92% |
| Cash from Operations | 32.05% | -67.32% | 2.71% | 1.96% | -17.28% |
| Capital Expenditure | -- | -- | -- | 100.00% | 96.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 175.94% | 60.60% | -349.18% | 1,042.53% | 75.63% |
| Cash from Investing | 175.94% | 60.60% | -349.18% | 1,041.37% | 75.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 316.10% | -99.91% | 272,506.52% | -99.41% | 73.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -46,328.57% | 99.78% | -- | -- | 100.00% |
| Cash from Financing | -1,234.23% | -99.91% | 265,443.48% | -99.41% | 76.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.06% | -185.76% | 445.34% | 212.88% | 51.67% |